N-[(3S)-1-benzylpyrrolidin-3-yl]-(2-thienyl)benzamides:: Human dopamine D4 ligands with high affinity for the 5-HT2A receptor

被引：11

作者：

Arora, J ^{[1
]}

Bordeleau, M ^{[1
]}

Dube, L ^{[1
]}

Jarvie, K ^{[1
]}

Mazzocco, L ^{[1
]}

Peragine, J ^{[1
]}

Tehim, A ^{[1
]}

Egle, I ^{[1
]}

机构：

[1] NPS Pharmaceut, Mississauga, ON L4V 1V7, Canada

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 23期

关键词：

dopamine; serotonin; schizophrenia; D4; 5-HT2A;

D O I：

10.1016/j.bmcl.2005.08.051

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of N-[(3S)-1-benzylpyrrolidin-3-y1]-(2-thienyl)benzamides 8 has been prepared and found to bind with high affinity to the human D-4 (hD(4)) and 5-HT2A receptors. Several compounds displayed selectivity for these receptors versus hD(2) and alpha(1), adrenergic receptors of over 500-fold. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：5253 / 5256

页数：4

共 20 条

[1] Current Strategies for the Development of Novel Antipsychotic Drugs
Bolos, Jordi
[J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2003, 3 (03) : 239 - 251
[2] Synthesis and preliminary pharmacological evaluation of 4′-arylalkyl analogues of clozapine.: II.: Effect of the nature and length of the linker
Capuano, B
Crosby, IT
Lloyd, EJ
Podloucka, A
Taylor, DA
[J]. AUSTRALIAN JOURNAL OF CHEMISTRY, 2003, 56 (09) : 875 - 886
[3] Synthesis and preliminary pharmacological evaluation of 4′-arylmethyl analogues of clozapine.: I.: The effect of aromatic substituents
Capuano, B
Crosby, IT
Lloyd, EJ
Taylor, DA
[J]. AUSTRALIAN JOURNAL OF CHEMISTRY, 2002, 55 (09) : 565 - 576
[4] Chaki S, 2000, CNS DRUG REV, V6, P95
[5] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6] N-(1-benzylpyrrolidin-3-yl)arylbenzamides as potent and selective human dopamine D4 antagonists
Egle, I
Barriault, N
Bordeleau, M
Drage, J
Dube, L
Peragine, J
Mazzocco, L
Arora, J
Jarvie, K
Tehim, A
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (19) : 4847 - 4850
[7] JL 13, an atypical antipsychotic:: A preclinical review
Ellenbroek, BA
Liégeois, JF
[J]. CNS DRUG REVIEWS, 2003, 9 (01): : 41 - 56
[8] The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D-4 receptor
Heuillet, E
Petitet, F
Mignani, S
Malleron, JL
Lavayre, J
Neliat, G
Doble, A
Blanchard, JC
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 314 (1-2) : 229 - 233
[9] The dopamine D4 receptor:: a controversial therapeutic target
Hrib, NJ
[J]. DRUGS OF THE FUTURE, 2000, 25 (06) : 587 - 611
[10] Kramer MS, 1997, ARCH GEN PSYCHIAT, V54, P567

← 1 2 →